GOLPH3 and cancer: Kaplan-Meier survival curves and log-rank test survival analyses showed that the overall survival, cancer-specific survival and progression-free survival of patients with low levels of GOLPH3 were significantly better than that for patients with high levels of GOLPH3 (all P < 0.05; Figure 1D).